Analysts: GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

47.29USD
17 Apr 2015
Change (% chg)

$-0.29 (-0.61%)
Prev Close
$47.58
Open
$47.33
Day's High
$47.40
Day's Low
$47.04
Volume
2,515,292
Avg. Vol
3,502,315
52-wk High
$56.48
52-wk Low
$41.25

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- December 18 Apr 2015

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 0 0 0 0
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.75 2.75 2.75 2.75

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-15 2 9,104.35 9,241.46 8,967.24 --
Quarter Ending Sep-15 2 9,364.71 9,470.99 9,258.43 --
Year Ending Dec-15 4 33,842.50 38,136.60 23,900.00 43,520.40
Year Ending Dec-16 4 34,403.50 38,062.70 24,264.00 43,175.60
Earnings (per share)
Year Ending Dec-15 3 2.73 2.81 2.66 3.93
Year Ending Dec-16 3 2.80 2.87 2.74 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-14 9,962.91 9,790.42 172.49 1.73
Quarter Ending Sep-14 10,139.10 9,428.82 710.28 7.01
Quarter Ending Jun-14 10,079.80 9,359.61 720.17 7.14
Quarter Ending Mar-14 9,846.03 9,317.58 528.45 5.37
Quarter Ending Dec-13 11,183.30 11,184.40 1.13 0.01
Earnings (per share)
Quarter Ending Sep-14 0.40 0.93 0.53 129.97
Quarter Ending Dec-13 0.96 0.97 0.01 1.04
Quarter Ending Dec-12 0.72 1.04 0.32 44.22
Quarter Ending Jun-12 0.66 0.83 0.17 26.35
Quarter Ending Mar-12 0.69 0.85 0.16 23.49

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-15 9,104.35 8,962.44 8,962.44 8,700.66 --
Quarter Ending Sep-15 9,364.71 9,428.93 9,428.93 9,405.51 --
Year Ending Dec-15 33,842.50 34,066.40 34,066.40 36,408.60 43,520.40
Year Ending Dec-16 34,403.50 34,691.20 34,691.20 37,792.20 43,175.60
Earnings (per share)
Year Ending Dec-15 2.73 2.73 2.73 2.77 3.93
Year Ending Dec-16 2.80 2.80 2.80 2.80 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-15 1 0 1 0
Quarter Ending Sep-15 0 1 0 1
Year Ending Dec-15 0 1 0 1
Year Ending Dec-16 0 1 0 1
Earnings
Year Ending Dec-15 0 0 0 0
Year Ending Dec-16 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks